Agilent Technologies sets $600 million note deal, shares supported by debt market access

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-29, 11:25.

Agilent Technologies (US00846U1016) has completed a new long-term financing step. The company closed a $600 million private placement of 4.900 percent senior notes due 2032, according to Marketscreener and company information.Marketscreener note on the private placement

Details of the new note

The private placement carries a 4.900 percent coupon and matures in 2032, giving Agilent Technologies fixed-rate funding over roughly six years.Agilent press release section The $600 million size is meaningful against a market capitalization in the mid tens of billions of dollars on the New York Stock Exchange.MarketWatch quote for Agilent

The senior notes are expected to rank equally with Agilent’s existing unsecured debt, preserving flexibility for operations and potential acquisitions. The deal follows the company’s May 27, 2026 second quarter report, where adjusted earnings per share beat consensus estimates.MarketBeat earnings summary

Analyst view and earnings backdrop

Agilent Technologies trades on the NYSE under the ticker A, with the latest regular-session close on June 26 at $136.29 per share, according to MarketBeat.MarketBeat news and price data Extended trading showed $134.42, indicating some volatility after the recent quarter.MarketBeat extended-hours quote

For the second quarter of 2026 reported on May 27, Agilent posted earnings per share of $1.49. That result exceeded the consensus estimate of $1.41 by $0.08, reflecting a modest upside versus analyst expectations.MarketBeat earnings details

Analyst data compiled by third-party platforms show an average price target around $160 per share. This implies upside compared with the latest $136 level, though individual targets and ratings differ by research house.Pandaforecast overview including analyst expectations

The business behind the stock

Agilent Technologies generates its revenue with analytical instruments, software and services for laboratories in life sciences, diagnostics and applied markets. A representative product line is its liquid chromatography and mass spectrometry systems used in pharmaceutical quality control and research.Agilent liquid chromatography portfolio

The company also offers genomic and pathology solutions for clinical diagnostics and research labs. Services such as installation, maintenance and method development complement the hardware to build recurring revenue streams.Agilent at a glance overview

Where the shares trade today

Agilent Technologies shares (US00846U1016) last traded on June 26, 2026 on the NYSE at $136.29 in regular hours, with Xetra data showing 119.10 euros for the German listing at the close on the same day.Marketscreener Xetra quote for Agilent

Disclaimer: This article is for information only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. Figures and dates are based on sources cited and may change. Investors should conduct their own research or consult a professional advisor.